results cisplatin fluorouracil infusion head neck cancer part developmental process Head Neck Intergroup trial adjuvant chemotherapy advanced resectable head neck carcinoma Radiation Therapy Oncology Group Philadelphia Pa nonrandomized pilot studies chemotherapy consisting courses cisplatin fluorouracil infusion Chemotherapy patients induction surgery additional patients sequential populations comparable respect site stage Twelve patients induction group sequential group alive evidence disease last follow-up median survival months sequential group months induction group patients complete clinical response induction chemotherapy alive patients induction chemotherapy undergo surgery lack surgery years survival groups different induction group sequential group 